Provided by Tiger Trade Technology Pte. Ltd.

Eledon Pharmaceuticals, Inc.

2.78
0.0000
Volume:357.00K
Turnover:991.63K
Market Cap:225.91M
PE:-2.82
High:2.86
Open:2.86
Low:2.75
Close:2.78
52wk High:4.60
52wk Low:1.35
Shares:81.26M
Float Shares:74.57M
Volume Ratio:0.44
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9867
EPS(LYR):-0.5566
ROE:-110.71%
ROA:-39.02%
PB:3.14
PE(LYR):-4.99

Loading ...

Guggenheim Sticks to Its Buy Rating for Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
Jun 23

Eledon Pharmaceuticals shareholders approve increase in authorized common shares to 450 million

Reuters
·
Jun 23

Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN) and MoonLake Immunotherapeutics (MLTX)

TIPRANKS
·
Jun 23

Eledon Says Mid-Stage Data Shows Tegoprubart Offers Higher Kidney Function, Improved Outcomes Compared with Tacrolimus

MT Newswires Live
·
Jun 22

Eledon posts American Transplant Congress presentation on tegoprubart kidney transplant data update

Reuters
·
Jun 22

Eledon says Phase 2 BESTOW extension shows higher kidney function with tegoprubart vs tacrolimus at 18 months

Reuters
·
Jun 22

Eledon Presents Long-Term Extension Phase 2 Bestow Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes With Tegoprubart Compared With Tacrolimus

THOMSON REUTERS
·
Jun 22

Noble Financial Sticks to Its Buy Rating for Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
Jun 11

Eledon Pharmaceuticals announces updated results from tegoprubart trial

TIPRANKS
·
Jun 08

Eledon Announces Updated Data From Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients With Type 1 Diabetes (T1d) at Uchicago Medicine

THOMSON REUTERS
·
Jun 08

Eledon says updated tegoprubart islet transplant trial data to be presented at ADA 2026 sessions

Reuters
·
Jun 05

Analysts Offer Insights on Healthcare Companies: Whitehawk Therapeutics (WHWK) and Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
May 22

Eledon presents new long-term Phase 2 BESTOW kidney transplant data for tegoprubart at ATC

Reuters
·
May 21

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
May 18

LifeSci Capital Remains a Buy on Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
May 14

BRIEF-Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results And Recent Business Highlights

Reuters
·
May 14

Eledon Pharma Q1 EPS $(0.33) Misses $(0.18) Estimate

Benzinga Earnings
·
May 14

Eledon Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 14

Eledon Pharmaceuticals Q1 net loss widens on warrant liability loss

Reuters
·
May 14

Eledon Q1 FY26 net loss widens to $39.03 million

Reuters
·
May 14